Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03318562
Title A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Effector Therapeutics
Indications

hepatocellular carcinoma

triple-receptor negative breast cancer

Therapies

Tomivosertib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
Kansas City Research Institute Kansas City Missouri 64131 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field